Rudolf Uher Selected Research

Nortriptyline (Aventyl)

1/2019	Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
1/2019	Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder.
10/2018	Genetic disposition to inflammation and response to antidepressants in major depressive disorder.
1/2016	Combining clinical variables to optimize prediction of antidepressant treatment outcomes.
12/2014	An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
2/2013	Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.
12/2012	Self-report and clinician-rated measures of depression severity: can one replace the other?
11/2012	Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression.
10/2012	Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.
4/2011	Changes in body weight during pharmacological treatment of depression.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rudolf Uher Research Topics

Disease

37	Major Depressive Disorder (Major Depressive Disorders) 04/2022 - 11/2009
10	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 04/2006
9	Depressive Disorder (Melancholia) 01/2019 - 03/2009
7	Obesity 07/2019 - 11/2009
6	Schizophrenia (Dementia Praecox) 04/2022 - 05/2014
6	Genetic Risk Score 01/2019 - 01/2014
5	Psychotic Disorders (Schizoaffective Disorder) 12/2020 - 01/2014
5	Inflammation (Inflammations) 10/2018 - 02/2013
3	Drug-Related Side Effects and Adverse Reactions 11/2021 - 09/2009
3	Anhedonia 01/2020 - 01/2018
3	Mental Disorders (Mental Disorder) 01/2020 - 01/2016
3	Weight Gain 07/2011 - 09/2009
2	Treatment-Resistant Depressive Disorder 01/2021 - 01/2019
2	Mood Disorders (Mood Disorder) 01/2020 - 06/2019
2	Overweight 01/2018 - 11/2009
2	Pain (Aches) 01/2017 - 01/2009
2	Insulin Resistance 01/2015 - 11/2014
2	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2011 - 09/2009
2	Body Weight (Weight, Body) 04/2011 - 11/2009
2	Neurobehavioral Manifestations 12/2010 - 03/2009
1	Morbid Obesity 10/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Syndrome (Syndromes) 01/2020
1	Dementia (Dementias) 12/2019
1	Postpartum Depression (Post-Natal Depression) 01/2019
1	Autism Spectrum Disorder 01/2018
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Intellectual Disability (Idiocy) 10/2017
1	Growth Disorders 01/2017
1	Dizziness (Lightheadedness) 07/2015
1	Type 2 Diabetes Mellitus (MODY) 01/2015
1	Atrophy 11/2014
1	Glucose Intolerance 11/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2014
1	Huntington Disease (Huntington's Disease) 11/2012
1	Weight Loss (Weight Reduction) 04/2011
1	Feeding and Eating Disorders (Eating Disorder) 04/2010
1	Bulimia (Binge Eating) 04/2010
1	Constipation 09/2009
1	Bulimia Nervosa 01/2009
1	Hallucinations (Hallucination) 04/2006

Drug/Important Bio-Agent (IBA)

35	Antidepressive Agents (Antidepressants)IBA 04/2022 - 09/2009
20	Escitalopram FDA Link 01/2020 - 03/2009
17	Nortriptyline (Aventyl)FDA LinkGeneric 01/2019 - 03/2009
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
7	Biological ProductsIBA 01/2022 - 01/2017
5	Pharmaceutical PreparationsIBA 11/2021 - 07/2011
4	LithiumIBA 11/2021 - 12/2012
4	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2018
3	C-Reactive ProteinIBA 10/2018 - 12/2014
3	Messenger RNA (mRNA)IBA 05/2014 - 02/2013
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2014 - 09/2010
3	CytokinesIBA 09/2013 - 02/2013
2	Aripiprazole (Abilify)FDA Link 01/2020 - 01/2019
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2019 - 12/2014
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2019 - 04/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 11/2014
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2014 - 01/2012
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2014 - 02/2013
1	cyclo(Arg-Pro) (CI 4)IBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Complement C4 (Complement Component 4)IBA 01/2020
1	Progesterone FDA LinkGeneric 01/2019
1	Testosterone (Sustanon)FDA Link 01/2019
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Tuberculin (PPD)IBA 01/2019
1	ProlactinIBA 01/2019
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Proteoglycans (Proteoglycan)IBA 01/2017
1	GlycosaminoglycansIBA 01/2017
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2017
1	Insulin (Novolin)FDA Link 01/2015
1	Vesicle-Associated Membrane Protein 2 (VAMP2)IBA 05/2014
1	Citalopram FDA LinkGeneric 09/2013
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 02/2013
1	Tacrolimus Binding Proteins (FKBP)IBA 02/2013
1	InterleukinsIBA 02/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2013
1	IntegrinsIBA 11/2012
1	Serotonin (5 Hydroxytryptamine)IBA 01/2012
1	salicylhydroxamic acid (SHAM)IBA 04/2010
1	Lamotrigine (Lamictal)FDA LinkGeneric 04/2006

Therapy/Procedure

3	Therapeutics 01/2019 - 05/2017
1	Precision Medicine 01/2019
1	Drug Therapy (Chemotherapy) 10/2013
1	Transcranial Magnetic Stimulation 04/2010
1	Analgesia 01/2009